Radiopharm Theranostics Limited
RADX · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $29 | $19 | $12 | $27 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $10 | $1 | $4 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $3 | $0 | $0 |
| Total Curr. Assets | $40 | $23 | $16 | $27 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $47 | $49 | $59 | $56 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $47 | $49 | $59 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $86 | $72 | $75 | $83 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $3 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $11 | $10 | $7 |
| Total Curr. Liab. | $15 | $18 | $13 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $27 | $16 | $13 |
| Total NC Liab. | $29 | $27 | $16 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $44 | $45 | $29 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $177 | $101 | $97 | $87 |
| Retained Earnings | -$146 | -$111 | -$65 | -$31 |
| AOCI | $13 | $38 | $10 | $7 |
| Other Equity | $1 | $1 | $2 | $0 |
| Total Equity | $45 | $28 | $44 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$2 | -$1 | $1 | $0 |
| Total Liab. & Tot. Equity | $86 | $72 | $75 | $83 |
| Net Debt | -$29 | -$19 | -$12 | -$27 |